Citalopram is an antidepressant belonging to the class of selective serotonin-reuptake inhibitors (SSRIs) widely used to treat the symptoms of depression. It is a racemic bicyclic phthalate derivate and is the only compound with a tertiary amine and 2 nitrogen-containing metabolites among all SSRIs. Citalopram enhances serotonergic transmission through the i...
Citalopram is approved by the FDA for treating adults with major depressive disorder. It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.
Sage Investigational Site, Bellevue, Washington, United States
University of Oxford, Oxford, United Kingdom
University of Oxford, Oxford, United Kingdom
King's College London, London, United Kingdom
Parexel International GmbH, Berlin, Germany
Charité - Universitätsmedizin Berlin, Berlin, Germany
Azienda Ospedaliera Universitaria Mater Domini, Università Magna Grecia, Catanzaro, Italy
Sapienza Università di Roma, Dipartimento di Neurologia e Psichiatria, Roma, Italy
Azienda Ospedaliera Universitaria Verona, Verona, Italy
Institute of Acupuncture and Moxibustion, Beijing, Beijing, China
University of Oxford, Oxford, Oxfordshire, United Kingdom
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.